Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01263249 · ClinicalTrials.gov registry record · Phase 4
Effects of Catheter Tip Location Relative to the Femoral Nerve on Sensory and Motor Function
A Phase 4 study of Continuous Femoral Nerve Blocks in Healthy Volunteers, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT01263249 is a Phase 4 study of Continuous Femoral Nerve Blocks in Healthy Volunteers that has completed, run by University of California, San Diego. The registered enrollment target is 19 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01263249, a Phase 4 study of Continuous Femoral Nerve Blocks in Healthy Volunteers, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine if the way local anesthetic, or numbing medication, is delivered through a tiny tube next to the nerves that go to the thigh affects the strength and sensation in the thigh.
Conditions Studied
Interventions
- PROCEDURE Catheter Anterior to the Femoral Nerve
- PROCEDURE Catheter Posterior to the Femoral Nerve
Study Locations (1)
California
- UCSD Medical Center, Hillcrest - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2010-01 |
| Est. Completion | 2011-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01263249
The ClinicalTrials.gov registry entry for NCT01263249 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Continuous Femoral Nerve Blocks in Healthy Volunteers appearing as the primary indexed condition, and to 2 interventions - of which Catheter Anterior to the Femoral Nerve is the first listed.
NCT01263249 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01263249 about?
NCT01263249 is a clinical study titled "Effects of Catheter Tip Location Relative to the Femoral Nerve on Sensory and Motor Function". To determine if the way local anesthetic, or numbing medication, is delivered through a tiny tube next to the nerves that go to the thigh affects the strength and sensation in the thigh.
What is the current status of trial NCT01263249?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2010-01. Estimated completion is 2011-06.
What conditions does trial NCT01263249 study?
This clinical trial studies the following conditions: Continuous Femoral Nerve Blocks in Healthy Volunteers.
What interventions are being tested in trial NCT01263249?
The interventions under investigation include: Catheter Anterior to the Femoral Nerve (PROCEDURE), Catheter Posterior to the Femoral Nerve (PROCEDURE).
Who is sponsoring clinical trial NCT01263249?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01263249 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.